Otsuka

heart balloon deflated
Biotech

Otsuka gives cancer candidates the kiss-off on strategic grounds

The Japanese drugmaker said strategic reasons—the pharma equivalent of “it’s not you, it’s me”—underpinned the decision to ax the assets.
Nick Paul Taylor Feb 14, 2025 5:30am
Front view of unrecognizable mature woman sitting at the table and typing a text message on her smart phone

FDA clears Otsuka, Click's prescription app for depression

Apr 3, 2024 1:53pm
graphic image of different colored hands shaking

Phenomic inks 2nd deal in 2 days, Shape adds to Roche pact

Nov 30, 2023 10:14am
Missed target failed trial trial failure

Sumitomo-Otsuka schizophrenia drug flunks pair of phase 3 trials

Jul 31, 2023 7:50am
Digital X-ray brain on blue background neurons

Schrödinger expands neuroscience work with BMS, Otsuka deals

Jan 9, 2023 10:43am
Woman tears agreement documents in front of agent

After dispute, Otsuka pays Akebia $55M to exit anemia pill pacts

Jul 1, 2022 8:15am